Detalhe da pesquisa
1.
Five new F10 variants in hereditary factor x deficiency detected by high-throughput sequencing.
Haemophilia
; 29(6): 1565-1572, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37842794
2.
A focus on dominant negative variants in a series of 170 heterozygous FXI-deficient patients.
Haemophilia
; 29(4): 1113-1120, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37252892
3.
Management of rare inherited bleeding disorders: Proposals of the French Reference Centre on Haemophilia and Rare Coagulation Disorders.
Eur J Haematol
; 110(6): 584-601, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36748278
4.
Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A-Final efficacy and safety results from the NuProtect study.
Eur J Haematol
; 111(4): 544-552, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37439123
5.
Biological, clinical features and modelling of heterozygous variants of glycoprotein Ib platelet subunit alpha (GP1BA) and glycoprotein Ib platelet subunit beta (GP1BB) genes responsible for constitutional thrombocytopenia.
Br J Haematol
; 199(5): 744-753, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36173017
6.
rFVIII-Fc in severe haemophilia A: The incentive switch in case of high risk of joint bleedings.
Eur J Clin Invest
; 52(10): e13824, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35699345
7.
Prostate biopsy and prostate cancer management in patients with haemophilia: The experience of French Haemophilia Treatment Centres.
Haemophilia
; 28(3): 437-444, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35201650
8.
Postauthorization safety surveillance study of antihaemophilic factor (recombinant) reconstituted in 2 mL sterile water for injection in children with haemophilia A.
Haemophilia
; 26(3): 478-486, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32338433
9.
Bleeding complications during pregnancy and delivery in haemophilia carriers and their neonates in Western France: An observational study.
Haemophilia
; 26(6): 1046-1055, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32842170
10.
Recombinant factor VIII products and inhibitor development in previously untreated boys with severe hemophilia A.
Blood
; 124(23): 3398-408, 2014 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-25253771
11.
Bleeding risk for patients with haemophilia under antithrombotic therapy. Results of the French multicentric study ERHEA.
Br J Haematol
; 185(4): 764-767, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30338508
12.
Matching-Adjusted Indirect Comparison of Recombinant Factor IX Albumin Fusion Protein Versus Recombinant Factor IX Fc Fusion Protein for Weekly Prophylactic Treatment of Hemophilia B.
Adv Ther
; 41(2): 649-658, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38070040
13.
The effectiveness and safety of octocog alfa in patients with hemophilia A: up to 7-year follow-up of the real-world AHEAD international study.
Ther Adv Hematol
; 15: 20406207231218624, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38371314
14.
Genotype-Dependent Response to Desmopressin in Hemophilia A and Proposal of a Predictive Response Score.
Thromb Haemost
; 2024 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38759975
15.
Key Drivers of Coagulation Factor Use in Von Willebrand Disease During Hospitalization: An Overview of the French BERHLINGO Cohort.
Clin Drug Investig
; 44(1): 35-49, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38036930
16.
Development of inhibitory antibodies to therapeutic factor VIII in severe hemophilia A is associated with microsatellite polymorphisms in the HMOX1 promoter.
Haematologica
; 98(10): 1650-5, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23716558
17.
A French Real-World Evidence Study Evaluating the Efficacy, Safety, and Pharmacokinetic Parameters of rVIII-SingleChain in Patients with Hemophilia A Receiving Prophylaxis.
Thromb Haemost
; 123(5): 490-500, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36758611
18.
Surgery in rare bleeding disorders: the prospective MARACHI study.
Res Pract Thromb Haemost
; 7(7): 102199, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37867585
19.
Continuous Infusion of Factor VIII and von Willebrand Factor in Surgery: Trials with pdFVIII LFB or pdVWF LFB in Patients with Bleeding Disorders.
Thromb Haemost
; 122(8): 1304-1313, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35642281
20.
Long-Term Antithrombotic Treatments Prescribed for Cardiovascular Diseases in Patients with Hemophilia: Results from the French Registry.
Thromb Haemost
; 121(3): 287-296, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33099283